ASH1L and neoplasm: IVIS imaging and ex vivo fluorescence imaging revealed that ASH1L depletion significantly suppressed tumor outgrowth in bone, but this effect was abolished by PX-478 treatment (Fig. 7h and Supplementary Fig. 9g).